Training for Academic Hematology

学术血液学培训

• 批准号: 7626277
• 负责人: VICTOR JACK MARDER
• 金额: $ 25.11万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-07-01 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7626277
• 关键词: Academic Training; Hematology

DESCRIPTION (provided by applicant): This application is for competitive renewal of a PHS Institutional National Service Award at the David Geffen School of Medicine at UCLA to prepare fellows for an academic career in Hematology. This award was initiated in July, 2002, and supports 4 fellowship slots in years 2 and 3 of Hematology/Medical Oncology training. Of 11 fellows who have entered the program, 4 are currently in training and 7 have completed their fellowship, of which 4 are on the full-time faculty at UCLA, two are in clinical trial development with industry, and one has entered clinical practice. The faculty consists of 31 academic scientists and physicians, grouped into four areas of mutual research interest, Hematopoiesis and Stem Cell Biology (Kenneth Dorshkind, PhD, Director), Leukemia (Gary Schiller, MD, Director), Lymphocyte Biology and Lymphoma (Alan Lichtenstein, MD, Director) and Hemostasis, Thrombosis and Vascular Biology (Victor Marder, MD, Director). The entire faculty have extramural research grant support, including 24 (77%) with NIH grants. Interaction with other training programs in complementary disciplines emphasizes our goal of interactive basic and translational research careers. A research retreat is; held each spring, during which time each mentor presents an overview of the laboratories' research interest, followed by a report of the respective fellows' progress. Formal review of the mentor's effectiveness and the fellow's progress and goals are prepared by the Steering Committee, made up of the four Focus Directors. A core curriculum is offered to all fellows, including a "Clinical Research Course", which covers subjects on research design and analysis, ethics, regulatory, issues, grant preparation and responsible conduct of research. Fellows are encouraged to obtain an advanced degree as part of the STAR program, with formal course work in appropriate departments for one or two additional years. Of the 7 fellows who have completed their program during the interval 2002 - present, 2 have obtained the Master's degree and 1 has received a PhD degree. The training of hematologists with expertise in basic, clinical and translational research is an important priority for the David Geffen School of Medicine at UCLA and this application seeks support for the pivotal period between clinical training and an eventual career in academic hematology.

描述（由申请人提供）： 此申请是在加州大学洛杉矶分校的大卫格芬医学院的PHS机构国家服务奖的竞争性更新，以准备在血液学的学术生涯研究员。该奖项于2002年7月启动，支持血液学/内科肿瘤学培训第2年和第3年的4个奖学金名额。在进入该计划的11名研究员中，有4名目前正在接受培训，7名已完成研究员资格，其中4名是加州大学洛杉矶分校的全职教师，两名正在与行业进行临床试验开发，一名已进入临床实践。该学院由31名学术科学家和医生组成，分为四个相互研究兴趣的领域，造血和干细胞生物学（Kenneth Dorshkind，博士，主任），白血病（加里席勒，医学博士，主任），淋巴细胞生物学和淋巴瘤（Alan Lichelman，医学博士，主任）和止血，血栓形成和血管生物学（维克托Marder，医学博士，主任）。整个学院都有校外研究资助支持，其中24人（77%）获得NIH赠款。与互补学科的其他培训计划的互动强调了我们的互动基础和转化研究职业的目标。研究撤退是;每年春季举行，在此期间，每位导师介绍了实验室的研究兴趣，然后报告了各自研究员的进展情况。指导委员会由四名重点主任组成，负责对指导员的有效性以及学员的进展和目标进行正式审查。向所有研究员提供核心课程，包括“临床研究课程”，内容涉及研究设计和分析、伦理、监管、问题、赠款准备和负责任地开展研究。鼓励研究员获得高级学位作为星星计划的一部分，在适当的部门正式课程工作一年或两年。在2002年至今完成方案的7名研究员中，2人获得硕士学位，1人获得博士学位。具有基础，临床和转化研究专业知识的血液学家的培训是加州大学洛杉矶分校大卫格芬医学院的一个重要优先事项，该申请旨在为临床培训和学术血液学最终职业生涯之间的关键时期提供支持。